{{Rsnum
|rsid=30740
|Chromosome=5
|position=135990901
|Orientation=plus
|GMAF=0.3012
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 47.8 | 40.7 | 11.5
| HCB | 40.9 | 48.2 | 10.9
| JPT | 50.4 | 43.4 | 6.2
| YRI | 62.6 | 33.3 | 4.1
| ASW | 42.1 | 49.1 | 8.8
| CHB | 40.9 | 48.2 | 10.9
| CHD | 35.8 | 46.8 | 17.4
| GIH | 56.4 | 33.7 | 9.9
| LWK | 60.9 | 36.4 | 2.7
| MEX | 51.7 | 39.7 | 8.6
| MKK | 57.7 | 34.6 | 7.7
| TSI | 59.8 | 35.3 | 4.9
| HapMapRevision=28
}}

{{PMID|17713557|OA=1
}} Visceral leishmaniasis (VL) caused by Leishmania chagasi is endemic to northeast Brazil. A positive delayed-type hypersensitivity skin test response (DTH+) is a marker for acquired resistance to disease. the DTH- phenotype was associated with SNP [[rs2070874]] at IL4 (OR 3.14; P=0.006; 95% CI=1.38-7.14), and SNP [[rs30740]] between LECT2 and TGFBI (OR 3.00; P=0.042; 95% CI=1.04-8.65)

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}